Skip to content

Patient-Centered Acupuncture for Pain (PCAP)

Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02152020
Enrollment
36
Registered
2014-06-02
Start date
2014-05-31
Completion date
2015-01-31
Last updated
2015-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivors

Brief summary

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Interventions

BEHAVIORALSurvey

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women or men age 18 years or older * Primary diagnosis of cancer with history of stage I, II, or III cancer * Finished primary cancer treatments (surgery, chemotherapy, radiotherapy) * Have a Karnofsky score of 60 or greater * Can understand written English * Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week * Have been taking pain medications daily * Have had at least 15 days with pain in the preceding 30 days.

Exclusion criteria

* Women or men with metastatic (stage IV) cancer * Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks * Planned surgical procedures in the next 12 weeks * Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization * Women who are pregnant or breastfeeding * Unwillingness to adhere to study related procedures.

Design outcomes

Primary

MeasureTime frame
Number of Adverse Events12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026